What initial levothyroxine dose should be started in a patient who was previously on levothyroxine 75 µg, stopped it, and now has a TSH of 120 mIU/L?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Restart at 75 µg levothyroxine immediately

For a patient who was previously on levothyroxine 75 µg, stopped taking it, and now has a TSH of 120 mIU/L, restart at the previous dose of 75 µg daily. This patient can resume their previously employed full replacement dose since the interruption appears to be less than 6 weeks and there is no mention of intercurrent cardiac events or marked weight loss 1.

Clinical Reasoning

Why Resume the Previous Dose?

The guidelines explicitly address this scenario: patients resuming L-thyroxine therapy after interruption (less than 6 weeks) without an intercurrent cardiac event or marked weight loss may resume their previously employed full replacement doses 1. The TSH of 120 mIU/L confirms severe hypothyroidism from medication non-adherence, but the patient's previous stable dose of 75 µg represents their known replacement requirement.

Age-Based Considerations

Critical caveat: If this patient is older than 50-60 years, you must assess for coronary heart disease before restarting at 75 µg:

  • Without cardiac disease: Can restart at 75 µg 1
  • With known cardiac disease or age >60: Start lower at 50 µg daily, then titrate up to avoid precipitating angina or atrial fibrillation 1

Alternative Approach for Unknown Previous Dose

If the previous dose were unknown, the TSH-based dosing strategy would apply. For TSH >12 mIU/L (and certainly >100 mIU/L), guidelines suggest starting at 75 µg daily 1. A randomized controlled trial demonstrated that TSH-based initial dosing (75 µg for TSH >12 mIU/L) achieved euthyroidism with minimal adjustments after 2 months 1.

Monitoring and Titration

  • Recheck TSH in 4-8 weeks after restarting therapy 1
  • Adjust dose in 12.5-25 µg increments based on TSH response 1
  • Goal TSH: normal reference range (generally 0.5-4.5 mIU/L) for primary hypothyroidism 1

Administration Instructions

Instruct the patient to take levothyroxine:

  • 30-60 minutes before breakfast with water, or
  • At bedtime, 4 hours after the last meal 1
  • Avoid taking with substances that interfere with absorption (calcium, iron, soy products, proton pump inhibitors) 1

Common Pitfalls to Avoid

  1. Do not start at a lower "cautious" dose unless the patient has cardiac disease or is elderly—this unnecessarily prolongs hypothyroidism
  2. Do not use weight-based dosing (1.6 µg/kg) when a previous stable dose is known—the patient already demonstrated their requirement
  3. Do not wait longer than 8 weeks to recheck TSH—earlier assessment prevents prolonged symptomatic hypothyroidism
  4. Address medication adherence to prevent recurrence—this TSH elevation suggests complete non-compliance

References

Guideline

clinical practice guidelines for hypothyroidism in adults: cosponsored by the american association of clinical endocrinologists and the american thyroid association.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.